Get started
Author

Shang‐Yi Huang

Observed names: S Huang, S Y Huang, S-Y. Huang, S. Huang, S.-Y. Huang, S.Y. Huang, S.‐Y. HUANG, SHANG‐YI HUANG, Shang-YI Huang, Shang-Yi Huang, Shang-yi Huang
Observed institutions: Amgen (United States), National Taiwan University, Chinese Academy of Medical Sciences & Peking Union Medical College, Chang Gung Memorial Hospital, Kaohsiung Chang Gung Memorial Hospital, Keelung Chang Gung Memorial Hospital, National Taiwan University Hospital, Changhua Christian Hospital, Takeda (Japan)
ORCID: 0000-0001-5688-3410
Observed ORCID: 0000-0001-5688-3410
OpenAlex ID: A5090611097
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
2009 · Jih-Luh Tang, Hsin-An Hou, et al. · Blood · 344
PDF
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
2011 · Wen-Chien Chou, Sheng-Chieh Chou, et al. · Blood · 322
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
2011 · Hsin-An Hou, Yuan-Yeh Kuo, et al. · Blood · 241
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
2018 · Meletios A Dimopoulos, Francesca Gay, et al. · The Lancet · 237
PDF
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
2010 · Wen-Chien Chou, Huai-Hsuan Huang, et al. · Blood · 227
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
2010 · Wen-Chien Chou, Hsin-An Hou, et al. · Blood · 204
PDF
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system
2010 · Hsin-An Hou, Tai-Chung Huang, et al. · Blood · 168
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
2012 · Shang-Ju Wu, Yuan-Yeh Kuo, et al. · Blood · 153
PDF
Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
2011 · Chien-Yuan Chen, Wang-Huei Sheng, et al. · BMC Infectious Diseases · 137
PDF
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
1998 · Shang‐Yi Huang, Cheng‐Shyong Chang, et al. · British Journal of Haematology · 131
Clinical profiles of multiple myeloma in Asia—An Asian Myeloma Network study
2014 · Kihyun Kim, Jae Hoon Lee, et al. · American Journal of Hematology · 122
PDF
Down-regulation of Phospho-Akt Is a Major Molecular Determinant of Bortezomib-Induced Apoptosis in Hepatocellular Carcinoma Cells
2008 · Kuen-Feng Chen, Pei-Yen Yeh, et al. · Cancer Research · 113
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
2018 · Bor-Sheng Ko, Yu-Fen Wang, et al. · EBioMedicine · 109
PDF
Epidemiology of multiple myeloma in Taiwan
2007 · Shang‐Yi Huang, Ming Yao, et al. · Cancer · 98
PDF
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
2013 · Chien‐Chin Lin, Hsin‐An Hou, et al. · American Journal of Hematology · 83
PDF
Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
2013 · Chien-Yuan Chen, Aristine Cheng, et al. · PLoS ONE · 82
PDF
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
2016 · Hsin-An Hou, Chieh-Yu Liu, et al. · Oncotarget · 81
PDF
Intracranial hemorrhage in adult patients with hematological malignancies
2012 · Chien-Yuan Chen, Chan-Hwei Tai, et al. · BMC Medicine · 81
PDF
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
2019 · Huai-Hsuan Huang, Fei-Yun Chen, et al. · BMC Cancer · 75
PDF
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival
2008 · Tiffany Ting-Fang Shih, Hsin-An Hou, et al. · Blood · 75
PDF
The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect
2010 · Shang-Ju Wu, Shang-Yi Huang, et al. · Blood · 74
PDF
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
2013 · Shang-Ju Wu, Jih-Luh Tang, et al. · American Journal of Hematology · 70
PDF
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
2015 · Chieh-Lung Cheng, Chi-Cheng Li, et al. · BMC Cancer · 64
PDF
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
2014 · Shang-Yi Huang, Chung-Wu Lin, et al. · Annals of Hematology · 62
PDF
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013
2017 · Chien-Yuan Chen, Feng-Ming Tien, et al. · International Journal of Antimicrobial Agents · 59
Works count: 150
Citation count: 5,179
H-index: 40
I10-index: 79
Year
Topic
Type